Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Opioids, Health Disparities and COVID-19: An Interview with Dr. Andrew Herring and Charles Hawthorne

Opioids, Health Disparities and COVID-19: An Interview with Dr. Andrew Herring and Charles Hawthorne

FromCompass Opioid Stewardship Expert Spotlight


Opioids, Health Disparities and COVID-19: An Interview with Dr. Andrew Herring and Charles Hawthorne

FromCompass Opioid Stewardship Expert Spotlight

ratings:
Length:
51 minutes
Released:
May 9, 2022
Format:
Podcast episode

Description

Hosts Don Stader, MD and Rachael Duncan, PharmD sit down with Andrew Herring, MD and Charles Hawthorne of CA Bridge to discuss healthy equity and disparities in the opioid epidemic. CA Bridge is a pioneering organization that expands access of evidence-based addiction care to those who use drugs across California, Andrew serves as the Director and Co-Principal Investigator and Charles is the Equity and Harm Reduction Project Manager. This episode explores the history of the opioid epidemic and where health disparities and access to care arose from. Tune in for an insightful conversation about how CA Bridge is paving the way forward to reduce health disparities and better utilize medication assisted treatment (MAT) to manage substance use disorder. Iowa Healthcare Collaborative presents the Compass Opioid Stewardship Expert Spotlight podcast in partnership with the Centers for Medicare and Medicaid Services. Visit their website for more information on the Compass Opioid Stewardship Program
Released:
May 9, 2022
Format:
Podcast episode

Titles in the series (15)

The Compass Opioid Stewardship Program aims to combat the opioid epidemic through education. The program aims to accomplish the following goals: 1. Educate and provide outreach to outlier prescribers of opioids about best practices for prescribing opioids 2. Educate and provide outreach to outlier prescribers of opioids about non-opioid pain management therapies 3. Reduce the amount of opioid prescriptions prescribed by eligible prescribers